At a Glance
Formulation: Premixed metronidazole injection 500 mg/100 mL (5 mg/mL), single-dose IV infusion bag. Preparation: Ready to use; no reconstitution, dilution or buffering is needed for this reference product. Do not add other medicines to the bag. Confirm product identity, expiry, container integrity and clarity.
Dose and administration
For serious susceptible anaerobic infections, adult labelled regimen includes an initial 15 mg/kg loading dose followed by 7.5 mg/kg every six hours, with a maximum 4 g/day; infusion should be slow, with the cited label describing approximately 5 mL/min. Dose depends on indication and local protocol. A 100 mL bag infused over 30–60 minutes corresponds to 200–100 mL/hour; follow the actual prescribed infusion duration and product insert rather than assuming this calculation is a universal order. Paediatric and neonatal doses require age/indication-specific approved references; do not extrapolate adult regimens.
Nursing workflow
- Confirm patient, anaerobic indication, allergies, prescribed dose, liver disease and interacting medicines.
- Verify 500 mg in 100 mL equals 5 mg/mL; inspect solution and packaging.
- Use sterile infusion equipment and a compatible dedicated line; avoid adding admixtures.
- Label administration and monitor infusion reactions, nausea and neurological symptoms.
Special populations and warnings
Severe hepatic impairment can require dose reduction; renal dialysis and premature infants require specific review. Assess pregnancy/lactation individually. Watch for peripheral neuropathy, seizures, encephalopathy, blood-count abnormalities, warfarin potentiation and disulfiram interaction. Review alcohol precautions and the current insert. Store as directed for the specific bag; this reference product says room temperature, protect from light and freezing.
Clinical Assessment and Indication Review
Document the suspected or confirmed anaerobic source, severity, source-control plan and relevant cultures. Metronidazole has no reliable aerobic coverage, so polymicrobial intra-abdominal infection may require additional agents. Reassess therapy when microbiology returns and avoid unnecessary duration.
Preparation and Administration Calculations
The premixed 500 mg/100 mL product is 5 mg/mL. For a prescribed full 500 mg bag, the volume is 100 mL. A 60-minute infusion of 100 mL is 100 mL/hour, while a 30-minute infusion is 200 mL/hour; these are mathematical examples only, not a substitute for the authorised label’s administration rate. Never assume another presentation has the same concentration.
Monitoring and Documentation
Review symptom response, fever, laboratory findings, liver function in significant hepatic disease, neurological symptoms with prolonged exposure, anticoagulant interactions and adverse effects. Document start and finish times, line assessment, infusion reaction and antimicrobial review date.
Frequently Asked Questions
Does this bag need dilution? Not for the specified premixed formulation. Can it be mixed with another drug? Only when verified compatibility data support the exact mixture. Is paediatric dosing the same? No; use age- and indication-specific guidance.
Primary Product Label
DailyMed / FDA-linked prescribing information. Preparation instructions are formulation-specific and must be verified against the locally stocked product.
MedBodh clinical education for trained healthcare professionals; not a patient-specific order. Verify institutional policy, renal adjustment, neonatal and pregnancy/lactation guidance.